Literature DB >> 24401079

Targeting a G-protein-coupled receptor overexpressed in endocrine tumors by magnetic nanoparticles to induce cell death.

Claire Sanchez1, Darine El Hajj Diab, Vincent Connord, Pascal Clerc, Etienne Meunier, Bernard Pipy, Bruno Payré, Reasmey P Tan, Michel Gougeon, Julian Carrey, Véronique Gigoux, Daniel Fourmy.   

Abstract

Nanotherapy using targeted magnetic nanoparticles grafted with peptidic ligands of receptors overexpressed in cancers is a promising therapeutic strategy. However, nanoconjugation of peptides can dramatically affect their properties with respect to receptor recognition, mechanism of internalization, intracellular trafficking, and fate. Furthermore, investigations are needed to better understand the mechanism whereby application of an alternating magnetic field to cells containing targeted nanoparticles induces cell death. Here, we designed a nanoplatform (termed MG-IONP-DY647) composed of an iron oxide nanocrystal decorated with a ligand of a G-protein coupled receptor, the cholecystokinin-2 receptor (CCK2R) that is overexpressed in several malignant cancers. MG-IONP-DY647 did not stimulate inflammasome of Raw 264.7 macrophages. They recognized cells expressing CCK2R with a high specificity, subsequently internalized via a mechanism involving recruitment of β-arrestins, clathrin-coated pits, and dynamin and were directed to lysosomes. Binding and internalization of MG-IONP-DY647 were dependent on the density of the ligand at the nanoparticle surface and were slowed down relative to free ligand. Trafficking of CCK2R internalized with the nanoparticles was slightly modified relative to CCK2R internalized in response to free ligand. Application of an alternating magnetic field to cells containing MG-IONP-DY647 induced apoptosis and cell death through a lysosomal death pathway, demonstrating that cell death is triggered even though nanoparticles of low thermal power are internalized in minute amounts by the cells. Together with pioneer findings using iron oxide nanoparticles targeting tumoral cells expressing epidermal growth factor receptor, these data represent a solid basis for future studies aiming at establishing the proof-of-concept of nanotherapy of cancers using ligand-grafted magnetic nanoparticles specifically internalized via cell surface receptors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24401079     DOI: 10.1021/nn404954s

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  22 in total

Review 1.  Penetration of the blood-brain barrier by peripheral neuropeptides: new approaches to enhancing transport and endogenous expression.

Authors:  M R Lee; R D Jayant
Journal:  Cell Tissue Res       Date:  2018-12-10       Impact factor: 5.249

2.  Peptide conjugated magnetic nanoparticles for magnetically mediated energy delivery to lung cancer cells.

Authors:  Anastasia K Hauser; Kimberly W Anderson; J Zach Hilt
Journal:  Nanomedicine (Lond)       Date:  2016-07-07       Impact factor: 5.307

3.  Intelligent Nanoparticles for Advanced Drug Delivery in Cancer Treatment.

Authors:  David S Spencer; Amey S Puranik; Nicholas A Peppas
Journal:  Curr Opin Chem Eng       Date:  2015-02       Impact factor: 5.163

4.  Nanoscale thermal phenomena in the vicinity of magnetic nanoparticles in alternating magnetic fields.

Authors:  Andreina Chiu-Lam; Carlos Rinaldi
Journal:  Adv Funct Mater       Date:  2016-03-31       Impact factor: 18.808

Review 5.  Magnetic nanoparticles and nanocomposites for remote controlled therapies.

Authors:  Anastasia K Hauser; Robert J Wydra; Nathanael A Stocke; Kimberly W Anderson; J Zach Hilt
Journal:  J Control Release       Date:  2015-09-25       Impact factor: 9.776

Review 6.  New paradigms in GPCR drug discovery.

Authors:  Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2015-08-08       Impact factor: 5.858

7.  Rotating magnetic field induced oscillation of magnetic particles for in vivo mechanical destruction of malignant glioma.

Authors:  Yu Cheng; Megan E Muroski; Dorothée C M C Petit; Rhodri Mansell; Tarun Vemulkar; Ramin A Morshed; Yu Han; Irina V Balyasnikova; Craig M Horbinski; Xinlei Huang; Lingjiao Zhang; Russell P Cowburn; Maciej S Lesniak
Journal:  J Control Release       Date:  2015-12-19       Impact factor: 9.776

8.  Biodistribution and in vivo activities of tumor-associated macrophage-targeting nanoparticles incorporated with doxorubicin.

Authors:  Mengmeng Niu; Youssef W Naguib; Abdulaziz M Aldayel; Yan-chun Shi; Stephen D Hursting; Matthew A Hersh; Zhengrong Cui
Journal:  Mol Pharm       Date:  2014-10-27       Impact factor: 4.939

9.  Non-Temperature Induced Effects of Magnetized Iron Oxide Nanoparticles in Alternating Magnetic Field in Cancer Cells.

Authors:  Sudath Hapuarachchige; Yoshinori Kato; Ethel J Ngen; Barbara Smith; Michael Delannoy; Dmitri Artemov
Journal:  PLoS One       Date:  2016-05-31       Impact factor: 3.240

10.  Magnetic particles with perpendicular anisotropy for mechanical cancer cell destruction.

Authors:  Rhodri Mansell; Tarun Vemulkar; Dorothée C M C Petit; Yu Cheng; Jason Murphy; Maciej S Lesniak; Russell P Cowburn
Journal:  Sci Rep       Date:  2017-06-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.